22-45414367-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015653.5(RIBC2):āc.175A>Gā(p.Lys59Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000393 in 1,551,304 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015653.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RIBC2 | NM_015653.5 | c.175A>G | p.Lys59Glu | missense_variant | 2/7 | ENST00000614167.2 | |
RIBC2 | XM_017028766.2 | c.175A>G | p.Lys59Glu | missense_variant | 2/5 | ||
RIBC2 | XM_005261524.5 | c.-45A>G | 5_prime_UTR_variant | 2/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RIBC2 | ENST00000614167.2 | c.175A>G | p.Lys59Glu | missense_variant | 2/7 | 1 | NM_015653.5 | P1 | |
RIBC2 | ENST00000621287.1 | n.45A>G | non_coding_transcript_exon_variant | 1/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152178Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000804 AC: 12AN: 149260Hom.: 0 AF XY: 0.0000630 AC XY: 5AN XY: 79376
GnomAD4 exome AF: 0.0000243 AC: 34AN: 1399008Hom.: 0 Cov.: 31 AF XY: 0.0000203 AC XY: 14AN XY: 690040
GnomAD4 genome AF: 0.000177 AC: 27AN: 152296Hom.: 0 Cov.: 31 AF XY: 0.000148 AC XY: 11AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2023 | The c.160A>G (p.K54E) alteration is located in exon 2 (coding exon 2) of the RIBC2 gene. This alteration results from a A to G substitution at nucleotide position 160, causing the lysine (K) at amino acid position 54 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at